We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
-24.04%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
-$350M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 40.96%
2 Industrials 32.45%
3 Technology 26.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.62B
$48.4M 39.94%
5,941,120
EMBK
2
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$32.2M 26.59%
3,186,008
EVLV icon
3
Evolv Technologies
EVLV
$1.01B
$28.2M 23.29%
10,601,281
RKLB icon
4
Rocket Lab Corp
RKLB
$39.9B
$11.1M 9.17%
2,929,350
DFTX
5
Definium Therapeutics
DFTX
$5.57B
$1.23M 1.02%
100,350

Similar funds

Data Collective IV's Q2 2022 Portfolio in Review

As of Q2 2022, Data Collective IV held 5 positions worth $121M, down 74% from $471M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Data Collective IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 9.4% a quarter earlier, followed by Industrials and Technology.

  • Data Collective IV's ten largest holdings make up 100% of its $121M portfolio in Q2 2022.
  • Data Collective IV opened 0 new positions and closed 0 in Q2 2022.
  • Data Collective IV's portfolio value fell 74% quarter-over-quarter to $121M.

Based on Data Collective IV's 13F filing for Q2 2022, filed 14 Nov 2022.